James Barry - 01 Sep 2024 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role
EVP, President, LSG
Signature
/s/ James Barry
Issuer symbol
BIO
Transactions as of
01 Sep 2024
Net transactions value
-$336,881
Form type
4
Filing time
04 Sep 2024, 20:24:59 UTC
Previous filing
08 May 2024
Next filing
10 Sep 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIO BIOB Bio-Rad A Common Stock Options Exercise $0 +250 +327% $0.000000 327 01 Sep 2024 Direct F1, F2
transaction BIO BIOB Bio-Rad A Common Stock Tax liability $30,359 -90 -28% $337.32 237 01 Sep 2024 Direct
transaction BIO BIOB Bio-Rad A Common Stock Options Exercise $0 +173 +73% $0.000000 410 01 Sep 2024 Direct F1
transaction BIO BIOB Bio-Rad A Common Stock Tax liability $20,914 -62 -15% $337.32 348 01 Sep 2024 Direct
transaction BIO BIOB Bio-Rad A Common Stock Options Exercise $0 +177 +51% $0.000000 525 01 Sep 2024 Direct F1
transaction BIO BIOB Bio-Rad A Common Stock Tax liability $21,588 -64 -12% $337.32 461 01 Sep 2024 Direct
transaction BIO BIOB Bio-Rad A Common Stock Options Exercise $0 +265 +58% $0.000000 726 02 Sep 2024 Direct F1
transaction BIO BIOB Bio-Rad A Common Stock Tax liability $32,045 -95 -13% $337.32 631 02 Sep 2024 Direct
transaction BIO BIOB Bio-Rad A Common Stock Options Exercise $0 +217 +34% $0.000000 848 03 Sep 2024 Direct F1
transaction BIO BIOB Bio-Rad A Common Stock Tax liability $26,076 -78 -9.2% $334.31 770 03 Sep 2024 Direct
transaction BIO BIOB Bio-Rad A Common Stock Sale $205,898 -623 -81% $330.49 147 04 Sep 2024 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIO BIOB Restricted Stock Units Options Exercise $0 -250 -25% $0.000000 752 01 Sep 2024 Bio-Rad A Common Stock 250 $0.000000 Direct F4, F5
transaction BIO BIOB Restricted Stock Units Options Exercise $0 -173 -33% $0.000000 348 01 Sep 2024 Bio-Rad A Common Stock 173 $0.000000 Direct F4, F6
transaction BIO BIOB Restricted Stock Units Options Exercise $0 -177 -50% $0.000000 178 01 Sep 2024 Bio-Rad A Common Stock 177 $0.000000 Direct F4, F7
transaction BIO BIOB Restricted Stock Units Options Exercise $0 -265 -100% $0.000000 0 02 Sep 2024 Bio-Rad A Common Stock 265 $0.000000 Direct F4, F8
transaction BIO BIOB Restricted Stock Units Options Exercise $0 -217 -100% $0.000000 0 03 Sep 2024 Bio-Rad A Common Stock 217 $0.000000 Direct F4, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of Class A common stock acquired on the vesting of restricted stock units.
F2 Includes 45.6820 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 06/30/2024.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $330.40 to $330.63, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F5 On September 1, 2023, the reporting person was granted 1,002 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
F6 On September 1, 2022, the reporting person was granted 694 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
F7 On September 1, 2021, the reporting person was granted 709 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
F8 On September 2, 2020, the reporting person was granted 1,059 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
F9 On September 3, 2019, the reporting person was granted 1,083 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.